MEDIANA Co.Ltd (041920) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MEDIANA Co.Ltd (041920) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.17 Billion ≈ $-1.47 Million USD) by net assets (₩132.36 Billion ≈ $89.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 041920 net asset quality index to measure how much of total assets are equity-financed.
MEDIANA Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how MEDIANA Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MEDIANA Co.Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
MEDIANA Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDIANA Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
|
N/A |
|
aTyr Pharma, Inc.
NASDAQ:ATYR
|
-0.181x |
|
Supra Boga Lestari Tbk
JK:RANC
|
0.149x |
|
HMCIB SPAC 3
KQ:226340
|
0.043x |
|
Hong Yi Fiber Industry Co Ltd
TW:1452
|
-0.021x |
|
Finger Inc.
KQ:163730
|
0.073x |
|
Rapala VMC Oyj
HE:RAP1V
|
0.083x |
|
Workpoint Entertainment Public Company Limited
BK:WORK
|
0.024x |
Annual Cash Flow Conversion Efficiency for MEDIANA Co.Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of MEDIANA Co.Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of MEDIANA Co.Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩127.80 Billion ≈ $86.61 Million |
₩5.11 Billion ≈ $3.46 Million |
0.040x | -72.40% |
| 2023-12-31 | ₩100.64 Billion ≈ $68.20 Million |
₩14.57 Billion ≈ $9.87 Million |
0.145x | +34.39% |
| 2022-12-31 | ₩90.06 Billion ≈ $61.03 Million |
₩9.70 Billion ≈ $6.57 Million |
0.108x | -30.11% |
| 2021-12-31 | ₩78.74 Billion ≈ $53.36 Million |
₩12.13 Billion ≈ $8.22 Million |
0.154x | +11.89% |
| 2020-12-31 | ₩68.31 Billion ≈ $46.29 Million |
₩9.41 Billion ≈ $6.38 Million |
0.138x | -35.63% |
| 2019-12-31 | ₩56.94 Billion ≈ $38.59 Million |
₩12.18 Billion ≈ $8.26 Million |
0.214x | +185.06% |
| 2018-12-31 | ₩49.44 Billion ≈ $33.51 Million |
₩3.71 Billion ≈ $2.51 Million |
0.075x | +224.52% |
| 2017-12-31 | ₩43.82 Billion ≈ $29.70 Million |
₩1.01 Billion ≈ $686.80K |
0.023x | -87.94% |
| 2016-12-31 | ₩42.75 Billion ≈ $28.97 Million |
₩8.20 Billion ≈ $5.56 Million |
0.192x | -12.75% |
| 2015-12-31 | ₩34.91 Billion ≈ $23.66 Million |
₩7.67 Billion ≈ $5.20 Million |
0.220x | +722.97% |
| 2014-12-31 | ₩27.30 Billion ≈ $18.50 Million |
₩728.97 Million ≈ $494.01K |
0.027x | -- |
About MEDIANA Co.Ltd
Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products th… Read more